Inspire Medical Systems, Inc. (INSP)

Market Cap	7.09B
Revenue (ttm)	624.80M
Net Income (ttm)	-21.15M
Shares Out	30.30M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	291,850
Open	227.63
Previous Close	225.22
Day's Range	225.58 - 234.55
52-Week Range	123.27 - 330.00
Beta	1.40
Analysts	Buy
Price Target	276.87 (+18.36%)
Earnings Date	May 7, 2024

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,011
• Stock Exchange: NYSE
• Ticker Symbol: INSP

Financial Performance

In 2023, INSP's revenue was $624.80 million, an increase of 53.19% compared to the previous year's $407.86 million. Losses were -$21.15 million, -52.87% less than in 2022.

Analyst Forecast

According to 15 analysts, the average rating for INSP stock is "Buy." The 12-month stock price forecast is $276.87, which is an increase of 18.36% from the latest price.

Price Target

$276.87

(18.36% upside)

Analyst Consensus: Buy